The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
December 25th 2023
Our most-read content that featured lung cancer included articles on non–small cell lung cancer, how navigation programs can increase screening rates, and a potential link between antidepressants and lung cancer risk.
December 14th 2023
Dr Melissa Johnson: COVID-19 Has Brought About Lasting Change to Medicine
September 18th 2020Melissa L. Johnson, MD, associate director for lung cancer research at Sarah Cannon Research Institute and partner in Tennessee Oncology, speaks on changes necessitated by the coronavirus disease 2019 (COVID-19) pandemic and connecting virtually.
Watch
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC
September 9th 2020Melissa L. Johnson, MD, associate director for lung cancer research at Sarah Cannon Research Institute and partner in Tennessee Oncology, discusses the potential of tiragolumab/atezolizumab for metastatic non–small cell lung cancer (NSCLC).
Watch
Dr Melissa Johnson: Treatment Advances Highlight the Immune System’s Importance in Lung Cancer
September 1st 2020Melissa L. Johnson, MD, associate director for lung cancer research at Sarah Cannon Research Institute and partner in Tennessee Oncology, discussed the biggest gains in the lung cancer space that have contributed to improved survival for patients.
Watch